India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
5G Network In today's time, there is no such person who does not use the Internet. Compared to before in our country of India, now people living in villages have started using the internet. The government of our country has also given the name of Digital India to India and all kinds of work in government offices are now being done in digital form i.e. with the help of internet. At present we are using 4G technology and now we are slowly moving towards 5G technology. In today's article, we are presenting all the information related to 5G network to all of you.